Microbix Presenting at StableView TECH19 Conference

StableView Asset Management is a full-service asset and wealth management firm that caters to individual clients and institutional investors.

StableView Asset Management (StableView) is a full-service asset and wealth management firm that caters to individual clients and institutional investors. Its investment process focuses on the preservation of wealth and capital, paying as little as possible for investments, reducing risk, and increasing returns. StableView was founded in 2012 and has held an investor conference annually since 2014. Further information about StableView and the TECH19 conference is available from its website at https://stableview.ca.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of financial results or the outlook for the business, risks associated with its financial results and stability, its biologicals business, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please visit www.microbix.com or www.sedar.com for recent Microbix filings.
For further information, please contact:

Cameron L. Groome, President & CEO
(905) 361-8910 x 350 cameron.groome@microbix.com
Jim Currie, CFO
(905) 361-8910 x 255 jim.currie@microbix.com
Deborah Honig, Investor Relations
Adelaide Capital Markets
(647) 203-8793 ir@microbix.com
Copyright © 2019 Microbix Biosystems Inc.
Microbix®, Kinlytic®, LumiSort™, and QAPs™ are trademarks of the Company

MORE ON THIS TOPIC